The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...

Respiratory syncytial virus, or RSV, is a common respiratory virus that typically causes mild, cold-like symptoms. According to the Centers for Disease Control and Prevention (CDC), most people who ...

After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV -- and more are on the way. On Wednesday, the US Food and Drug Administration ...

Guidelines recommend a single dose of RSV vaccine for older adults, but long-term data on the duration of protection is limited. In this study of U.S. veterans, effectiveness slid from over 80% in the ...

Patients aged 75 years or older who are not immunocompromised should receive a protein subunit respiratory syncytial virus (RSV) vaccine, according to new recommendations from the American College of ...

The updated guideline also strongly recommends RSV vaccination in adults and adolescents with compromised immunity. RSV ...

Healthcare professionals may recommend getting specific vaccines or immunizations to help prevent certain illnesses and protect your overall health. Vaccines help protect against diseases before they ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A 5-percentage-point increase in vaccine uptake could avert over 222,000 LRTD ...

FDA expansion of the Arexvy vaccine provides protection against RSV-related lower respiratory tract disease for at-risk adults aged 18 to 49 years. The Food and Drug Administration (FDA) has expanded ...

New research highlights the effectiveness of RSV preF vaccines in preventing severe respiratory infections in older adults. RSV is increasingly recognized as a substantial contributor to morbidity and ...